Advertisement

Bronchopulmonary Dysplasia: Strategies for Therapeutic Intervention

  • A. K. Tanswell
  • M. Liu
  • M. Post
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 25)

Abstract

Bronchopulmonary dysplasia (BPD), or chronic neonatal lung injury, is a chronic pneumopathy most commonly seen in preterm newborn infants requiring prolonged respiratory support. It was first described in the mid-1960’s, following the introduction of effective and commercially available neonatal ventilators which allowed the extended survival of infants with severe pulmonary insufficiency. Bronchopulmonary dysplasia has become the commonest chronic lung disease seen in infancy, with there being some 7000 new cases per year in the USA in the early 1980s [1]. The increased survival of extremely low birth weight infants over the last decade is likely to have increased this number significantly. The increased representation of extremely low birth weight infants in the overall pool of infants developing BPD has also been associated with a change in the expected radiological and pathological features associated with evolving BPD. When first described, there appeared to be a fairly clear, and well correlated, sequence of changes on X-ray (XR) and in lung histology occurring in the relatively large infants surviving with BPD in that era. The XR changes were divided into four stages, with stage I having the characteristic features of neonatal respiratory distress syndrome (RDS), followed by an opacification of the lung fields in stage II, which was associated with thick airway exudates, necrosis of respiratory epithelium and evidence of early repair. Survival into stage III represented a transition stage into chronic lung injury with areas of emphysematous alveoli being adjacent to patches of alveolar atelectasis and fibrosis reflected in the XR by rounded areas of radiolucency superimposed on lung fields of increased radiodensity.

Keywords

Lung Injury Bronchopulmonary Dysplasia High Frequency Oscillatory Ventilation Ureaplasma Urealyticum Exogenous Surfactant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Farell PM, Palta M (1986) Bronchopulmonary dysplasia. In: Far ell PM, Tausig LM (eds) Bronchopulmonary dysplasia and isolated chronic respiratory disorders, Ross Laboratories, Columbus, Ohio, pp 1–7.Google Scholar
  2. 2.
    Chambers HM, van Velzen D (1989) Ventilator-related pathology in the extremely immature lung. Pathology 21:79–83.PubMedCrossRefGoogle Scholar
  3. 3.
    Van Lierde S, Cornelis A, Devlieger H, Moerman P, Lauweryns J, Eggermont E (1991) Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia? Biol Neonate 60:152–162.PubMedCrossRefGoogle Scholar
  4. 4.
    Wohl MEB (1990) Bronchopulmonary dysplasia in adulthood. N Eng J Med 323:1834–1836.CrossRefGoogle Scholar
  5. 5.
    Rosenfeld W, Evans H, Concepcion L, Jhaveri R, Schaeffer H, Friedman A (1984) Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr 105:781–785.PubMedCrossRefGoogle Scholar
  6. 6.
    Tanswell AK, Freeman BA (1995) Antioxidant therapy in critical care medicine. New Horizons 3:330–341.PubMedGoogle Scholar
  7. 7.
    Frank L, McLaughlin GE (1993) Protection against acute and chronic hyperoxic inhibition of neonatal rat lung development with the 21-aminosteroid drug U74389F. Pediatr Res 33:632–638.PubMedCrossRefGoogle Scholar
  8. 8.
    Tsuno K, Miura K, Takeya M, Kolobow T, Morioka M (1991) Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures. Am Rev Respir Dis 143:1115–1120.PubMedGoogle Scholar
  9. 9.
    Nilsson R, Grossmann G, Robertson B (1980) Pathogenesis of neonatal lung lesions induced by artificial ventilation: evidence against the role of barotrauma. Respiration 40:218–225.PubMedCrossRefGoogle Scholar
  10. 10.
    Kawano T, Mori S, Cybulsky M, et al (1987) Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol 62:27–33.PubMedGoogle Scholar
  11. 11.
    Matsuoka T, Kawano T, Gamsu HR (1994) Role of high-frequency ventilation in surfactant-depleted lung injury as measured by granulocytes. J Appl Physiol 76:539–544.PubMedGoogle Scholar
  12. 12.
    Liu M, Xu J, Liu J, Kraw ME, Tanswell AK, Post M (1995) Mechanical strain-enhanced fetal lung cell proliferation is mediated by phospholipases C and D and protein kinase C. Am J Physiol 268:L729-L738.PubMedGoogle Scholar
  13. 13.
    Koppel R, Han RNN, Cox D, Tanswell AK, Rabinovitch M (1994) α1-antitrypsin protects neonatal rats from pulmonary vascular and parenchymal effects of oxygen toxicity. Pediatr Res 36:763–770.PubMedCrossRefGoogle Scholar
  14. 14.
    King RJ, Coalson J J, deLemos RA, Gerstmann DR, Seidner SR (1995) Surfactant protein-A deficiency in a primate model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 151:1989–1997.PubMedGoogle Scholar
  15. 15.
    Clements JA, Goerke J, Wright JR, Beppu O (1984) Turnover of lung surfactant. Prog Respir Res 18:133–142.Google Scholar
  16. 16.
    Post M (1996) Tissue interactions. In: Crystal RG, West JB, Weibel E, Barnes PJ (eds) The lung: Scientific foundations, 2nd edn. Raven Press, New York, In Press.Google Scholar
  17. 17.
    Tanswell AK, Buch S, Liu M, Post M (1996) Factors mediating cell growth in lung injury. In: Bland RD, Coalson J (eds) Chronic lung disease in early infancy. Marcel Dekker, New York, In Press.Google Scholar
  18. 18.
    Bonikos DS, Bensch KG, Northway WH, Edwards DK (1976) Bronchopulmonary dysplasia: the pulmonary pathological sequel of necrotizing bronchiolitis and pulmonary fibrosis. Human Pathol 7:643–666.CrossRefGoogle Scholar
  19. 19.
    Hamacher J, Schaberg T (1994) Adhesion molecules in lung disease. Lung 172:189–213.PubMedCrossRefGoogle Scholar
  20. 20.
    Crouch E (1990) Pathobiology of pulmonary fibrosis. Am J Physiol 259:L159-L184.PubMedGoogle Scholar
  21. 21.
    Jonsson B, Karell A-C, Ringertz S, Rylander M, Faxelius G (1995) Neonatal Ureaplasma urealyticum colonization and chronic lung disease. Acta Paediatr 83:927–930CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • A. K. Tanswell
  • M. Liu
  • M. Post

There are no affiliations available

Personalised recommendations